Analytical Chemistry · 2019 · 208 citations · 21 references
PharmacyOncologyPharmaceuticsChemotherapyDrug DeliveryTargeted Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineTargeting LigandsCancer Targeting LigandsCellular Uptake EfficiencyExosomesExosomes In CancerMolecular Targeting LigandsNanoparticle Cellular UptakeNanoparticle-based ChemotherapyTumor Targeting Ligands
Exosomes are nanoscale natural vehicles that transport biomolecules for cell‑to‑cell communication and hold promise for therapeutic delivery, yet enhancing their capacity through functionalization with targeting ligands and understanding their uptake mechanisms remains a challenge. This study aims to develop an aptamer‑functionalized exosome platform using diacyllipid–aptamer conjugates for cell‑type‑specific delivery of therapeutics and to elucidate its cellular uptake mechanism. The authors functionalized exosomes with diacyllipid–aptamer conjugates to create Apt‑Exos, a nanoplatform designed for targeted delivery of molecular therapeutics. Apt‑Exos exhibited distinct uptake behavior compared to free exosomes and efficiently delivered drugs or fluorophores to cancer cells, demonstrating a promising platform for cancer theranostics.
Exosomes (Exos) are nanoscale natural vehicles for transporting biomolecules to facilitate cell-to-cell communication, indicating a high potential of them for delivering therapeutics/diagnostics. To improve their delivery capacity, a simple, noninvasive, and efficient strategy for functionalizing Exos with effective targeting ligands as well as elucidation of the cellular uptake mechanism of these functionalized Exos was found be to necessary, but remained a challenge. In this work, we used diacyllipid–aptamer conjugates as the targeting ligand to develop an aptamer-functionalized Exos (Apt-Exos) nanoplatform for cell type-specific delivery of molecular therapeutics. The cellular uptake mechanism of Apt-Exos was investigated in details, and distinct behavior was observed in comparison to free Exos. By combining the excellent molecular recognition capability of aptamers and the superiority of Exos as natural vehicles, Apt-Exos can efficiently deliver molecular drugs/fluorophores to target cancer cells, providing a promising delivery platform for cancer theranostics.
21
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez‐Erviti, Yiqi Seow, HaiFang Yin et al. · Nature Biotechnology · 2011 · 4.8K citations
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar, Valerie S. LeBleu, Hikaru Sugimoto et al. · Nature · 2017 · 2.6K citations
Medicine, Cancer Biology, Oncology +13
Dynasore, a Cell-Permeable Inhibitor of Dynamin
Eric Macia, Marcelo Ehrlich, Ramiro Massol et al. · Developmental Cell · 2006 · 2K citations · Full text
Yanhua Tian, Suping Li, Jian Song et al. · Biomaterials · 2013 · 1.8K citations
Pharmacy, Oncology, Pharmaceutics +16